Coronary Heart Disease Risk Higher With COPD
Patients with COPD are more likely to have coronary heart disease (CHD), but no specific phenotypes have a higher risk.
Patients with COPD are more likely to have coronary heart disease (CHD), but no specific phenotypes have a higher risk.
A study presented at ACC 2022 found no significant association between high-dose corticosteroids and incident AF in patients with COVID-19.
What are the prognostic implications of using pulmonary artery catheters to monitor patients with cardiogenic shock?
A study was conducted to evaluate the evolution and prognostic value of TAPSE/PASP ratio in cardiac resynchronization therapy recipients.
Authors of a systematic review report on the impact of race and/or skin tone on the effectiveness of consumer wearable technology to measure heart rate and rhythm.
Adults with a history of allergic disorders have an increased likelihood of hypertension and coronary heart disease (CHD).
For males and females in all age groups, the risks for cardiac complications are higher after SARS-CoV-2 infection than after mRNA COVID-19 vaccination.
For patients with ASCVD, the treatment benefit of smoking cessation is equivalent to the use of targeted pharmaceutical interventions in persistent smokers.
To what extent is heart failure appropriately diagnosed and treated among patients hospitalized with COPD exacerbations, who are known to be at risk for HF?
A retrospective study was conducted to examine 3-year complications among patients with obstructive sleep apnea who received transcatheter aortic valve replacement.